1. Retention in care and antiretroviral therapy adherence among Medicaid beneficiaries with HIV, 2001–2015.
- Author
-
Rudolph, Jacqueline E., Calkins, Keri L., Zhang, Xueer, Zhou, Yiyi, Xu, Xiaoqiang, Wentz, Eryka L., Joshu, Corinne E., and Lau, Bryan
- Subjects
- *
CLINICAL drug trials , *MEDICAID , *PATIENT compliance , *ANTIRETROVIRAL agents , *RESEARCH funding , *OUTPATIENT services in hospitals , *HEALTH insurance , *HIV infections , *CONTINUUM of care , *DESCRIPTIVE statistics , *NONPARAMETRIC statistics - Abstract
Disparities in HIV care by socioeconomic status, place of residence, and race/ethnicity prevent progress toward epidemic control. No study has comprehensively characterized the HIV care cascade among people with HIV enrolled in Medicaid – an insurance source for low-income individuals in the US. We analyzed data from 246,127 people with HIV enrolled in Medicaid 2001–2015, aged 18–64, living in 14 US states. We estimated the monthly prevalence of four steps of the care cascade: retained in care/adherent to ART; retained/not adherent; not retained/adherent; not retained/not adherent. Beneficiaries were retained in care if they had an outpatient care encounter every six months. Adherence was based on medication possession ratio. We estimated prevalence using a non-parametric multi-state approach, accounting for death as a competing event and for Medicaid disenrollment using inverse probability of censoring weights. Across 2001–2015, the proportion of beneficiaries with HIV who were retained/ART adherent increased, overall and in all subgroups. By 2015, approximately half of beneficiaries were retained in care, and 42% of beneficiaries were ART adherent. We saw meaningful differences by race/ethnicity and region. Our work highlights an important disparity in the HIV care cascade by insurance status during this time period. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF